Logo image of PEI

PENN REAL ESTATE INVEST TST (PEI) Stock Fundamental Analysis

NYSE:PEI - New York Stock Exchange, Inc. - US7091028008 - REIT - Currency: USD

2.39  -0.01 (-0.42%)

After market: 2.57 +0.18 (+7.53%)

Fundamental Rating

2

Overall PEI gets a fundamental rating of 2 out of 10. We evaluated PEI against 128 industry peers in the Diversified REITs industry. PEI has a bad profitability rating. Also its financial health evaluation is rather negative. PEI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year PEI was profitable.
PEI had a positive operating cash flow in the past year.
PEI Yearly Net Income VS EBIT VS OCF VS FCFPEI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M -100M -200M

1.2 Ratios

The profitability ratios for PEI are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PEI Yearly ROA, ROE, ROICPEI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 -200 -400 -600 -800

1.3 Margins

The Operating Margin of PEI (4.53%) is worse than 86.10% of its industry peers.
PEI's Operating Margin has declined in the last couple of years.
The Profit Margin and Gross Margin are not available for PEI so they could not be analyzed.
Industry RankSector Rank
OM 4.53%
PM (TTM) N/A
GM N/A
OM growth 3Y-63.77%
OM growth 5Y-49.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PEI Yearly Profit, Operating, Gross MarginsPEI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 50 -50

1

2. Health

2.1 Basic Checks

PEI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PEI has less shares outstanding
The debt/assets ratio for PEI is higher compared to a year ago.
PEI Yearly Shares OutstandingPEI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M
PEI Yearly Total Debt VS Total AssetsPEI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.2 Solvency

PEI has a debt to FCF ratio of 36.68. This is a negative value and a sign of low solvency as PEI would need 36.68 years to pay back of all of its debts.
The Debt to FCF ratio of PEI (36.68) is better than 72.19% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 36.68
Altman-Z N/A
ROIC/WACCN/A
WACC3.78%
PEI Yearly LT Debt VS Equity VS FCFPEI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 500M 1B 1.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

2

3. Growth

3.1 Past

PEI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -78.12%.
The Revenue has grown by 8.17% in the past year. This is quite good.
PEI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.81% yearly.
EPS 1Y (TTM)-78.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1312.5%
Revenue 1Y (TTM)8.17%
Revenue growth 3Y-6.48%
Revenue growth 5Y-5.81%
Sales Q2Q%1.5%

3.2 Future

Based on estimates for the next years, PEI will show a very strong growth in Earnings Per Share. The EPS will grow by 22.63% on average per year.
PEI is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -25.86% yearly.
EPS Next Y82.48%
EPS Next 2Y35.8%
EPS Next 3Y22.63%
EPS Next 5YN/A
Revenue Next Year-50.93%
Revenue Next 2Y-33.38%
Revenue Next 3Y-25.86%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PEI Yearly Revenue VS EstimatesPEI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
PEI Yearly EPS VS EstimatesPEI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 3.46, which indicates a rather cheap valuation of PEI.
Based on the Price/Earnings ratio, PEI is valued cheaper than 97.86% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.65. PEI is valued rather cheaply when compared to this.
The Forward Price/Earnings Ratio is negative for PEI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 3.46
Fwd PE N/A
PEI Price Earnings VS Forward Price EarningsPEI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

75.40% of the companies in the same industry are more expensive than PEI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, PEI is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.27
EV/EBITDA 13.39
PEI Per share dataPEI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEI's earnings are expected to grow with 22.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y35.8%
EPS Next 3Y22.63%

0

5. Dividend

5.1 Amount

No dividends for PEI!.
Industry RankSector Rank
Dividend Yield N/A

PENN REAL ESTATE INVEST TST

NYSE:PEI (12/15/2022, 8:16:44 PM)

After market: 2.57 +0.18 (+7.53%)

2.39

-0.01 (-0.42%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A N/A
Earnings (Next)03-13 2023-03-13
Inst Owners0%
Inst Owner Change0%
Ins Owners30.89%
Ins Owner Change0%
Market Cap12.83M
Analysts45
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.46
Fwd PE N/A
P/S 0.04
P/FCF 0.27
P/OCF 0.19
P/B N/A
P/tB N/A
EV/EBITDA 13.39
EPS(TTM)0.69
EY28.87%
EPS(NY)-1.19
Fwd EYN/A
FCF(TTM)8.93
FCFY373.8%
OCF(TTM)12.89
OCFY539.2%
SpS55.98
BVpS-14.72
TBVpS-16.44
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 4.53%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-63.77%
OM growth 5Y-49.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 36.68
Debt/EBITDA 13.46
Cap/Depr 18.12%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC3.78%
ROIC/WACCN/A
Cap/Depr(3y)58.34%
Cap/Depr(5y)79.62%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-78.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1312.5%
EPS Next Y82.48%
EPS Next 2Y35.8%
EPS Next 3Y22.63%
EPS Next 5YN/A
Revenue 1Y (TTM)8.17%
Revenue growth 3Y-6.48%
Revenue growth 5Y-5.81%
Sales Q2Q%1.5%
Revenue Next Year-50.93%
Revenue Next 2Y-33.38%
Revenue Next 3Y-25.86%
Revenue Next 5YN/A
EBIT growth 1Y148.43%
EBIT growth 3Y-66.11%
EBIT growth 5Y-52.58%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y167.94%
FCF growth 3Y91.43%
FCF growth 5Y37.48%
OCF growth 1Y202.14%
OCF growth 3Y-20.04%
OCF growth 5Y-14.11%